Merck Caspofungin Acetate Injection Product Leaflet

Injection of Caspofungin Acetate is the acetate of caspofungin. It is indicated for the treatment of adult and pediatric patients (three months or older) with: Empirical therapy for suspected fungal infection in neutropenic patients with fever; Treatment of invasive aspergillosis in patients who have failed or are intolerant to other therapies.


Brand
Merck
Document type
Product Leaflet
Language
Chinese
Pages
14
File format
PDF
File size
223 KB
Updated
30 September, 2023
MD5 checksum
C78C42016852BF02F2D5054E2FE5AE4C

About this manual

This leaflet provides detailed guidance on the indications, dosage, and preparation of caspofungin acetate for injection. It includes recommended infusion times, dosage adjustments for special populations, and contraindications.

The document also covers stability, storage conditions, adverse reaction monitoring, and regulatory information for the product marketed under the brand Cancidas. This manual is written in Chinese.

What's inside

  • Indications
  • Dosage and Administration
  • Preparation of Injection Solution
  • Contraindications
  • Adverse Reactions
  • Pharmacokinetics
  • Storage
  • Packaging
  • Regulatory Information

Specifications

Molecular weight1213.42
Molecular formulaC27H36N8O6S2
Available strengths50 mg and 70 mg (as caspofungin)
Reconstituted concentration (50 mg vial)5.2 mg/mL
Unopened storage temperature2 °C to 8 °C

Frequently asked questions

What is the recommended infusion time for caspofungin acetate?

The infusion should be administered slowly over about one hour.

Can the reconstituted solution be mixed with other drugs?

No, it must not be mixed with any other medication or infusion fluid because compatibility data are lacking.

Download PDF (223 KB)

More Merck Manuals


View all Merck manuals →